A conserved matrix epitope based DNA vaccine protects mice against influenza A virus challenge

Antiviral Research

Volumn 93, Issue 1, 2012, Pages 78-85

  Kumar, Prashant ^a   Khanna, Madhu ^a   Kumar, Binod ^a   Rajput, Roopali ^a   Banerjea, Akhil C ^b  

^a UNIVERSITY OF DELHI   (India)

^b JAWAHARLAL NEHRU UNIVERSITY   (India)

Author keywords

Epitope; Influenza; Vaccine

Indexed keywords

DNA VACCINE; EPITOPE; GAMMA INTERFERON; INTERLEUKIN 12; MATRIX PROTEIN; PLASMID DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DRUG EFFICACY; IMMUNIZATION; INFLUENZA A; INFLUENZA VIRUS A; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; TH1 CELL; VIRUS REPLICATION;

ANIMALS; CELL LINE; CHICK EMBRYO; CHO CELLS; CRICETINAE; DOGS; EPITOPES; INFLUENZA A VIRUS; INFLUENZA VACCINES; MICE; MICE, INBRED BALB C; ORTHOMYXOVIRIDAE INFECTIONS; PLASMIDS; SPLEEN; T-LYMPHOCYTES, CYTOTOXIC; VACCINES, DNA; VIRAL MATRIX PROTEINS;

INFLUENZA A VIRUS; MUS; ORTHOMYXOVIRIDAE;

EID: 84355166402     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2011.10.021     Document Type: Article

References (36)

1. Braciale T.J. Immunologic recognition of influenza virus-infected cells. II. Expression of influenza A matrix protein on the infected cell surface and its role in recognition by cross-reactive cytotoxic T cells. J. Exp. Med. 1977, 146:673-689.
2. Bright R.A., Carter D.M., Crevar C.J., Toapanta F.R., Steckbeck J.D., Cole K.S., Kumar N.M., Pushko P., Smith G., Tumpey T.M., Ross T.M. Cross-clade protective immune responses to influenza viruses with H5N1 HA and NA elicited by an influenza virus-like particle. PLoS One 2008, 3:e1501.
3. Brown E.G., Liu H., Kit L.C., Baird S., Nesrallah M. Pattern of mutation in the genome of influenza A virus on adaptation to increased virulence in the mouse lung: identification of functional themes. Proc. Natl. Acad. Sci. USA 2001, 98:6883-6888.
4. Christensen J.P., Stenvang J.P., Marker O., Thomsen A.R. Characterization of virus-primed CD8+ T cells with a type 1 cytokine profile. Int. Immunol. 1996, 8:1453-1461.
5. Doherty P.C. Cell mediated immunity in virus infections. Biosci. Rep. 1997, 17:367-387.
6. Epstein S.L., Lo C.Y., Misplon J.A., Bennink J.R. Mechanism of protective immunity against influenza virus infection in mice without antibodies. J. Immunol. 1998, 160:322-327.
7. Fu T.M., Guan L., Friedman A., Schofield T.L., Ulmer J.B., Liu M.A., Donnelly J.J. Dose dependence of CTL precursor frequency induced by a DNA vaccine and correlation with protective immunity against influenza virus challenge. J. Immunol. 1999, 162:4163-4170.
8. Hu J., Cladel N.M., Budgeon L.R., Reed C.A., Pickel M.D., Christensen N.D. Protective cell-mediated immunity by DNA vaccination against papillomavirus L1 capsid protein in the cottontail rabbit papillomavirus model. Viral Immunol. 2006, 19:492-507.
9. Jamali A., Sabahi F., Bamdad T., Hashemi H., Mahboudi F., Kheiri M.T. A DNA vaccine-encoded nucleoprotein of influenza virus fails to induce cellular immune responses in a diabetic mouse model. Clin. Vaccine Immunol. 2010, 17:683-687.
10. Jansen A.G.S.C., Sanders E.A.M., Hoes A.W., van Loon A.M., Hak E. Influenza- and respiratory syncytial virus-associated mortality and hospitalisations. Eur. Respir. J. 2007, 30:1158-1166.
11. Johnson P.A., Conway M.A., Daly J., Nicolson C., Robertson J., Mills K.H.G. Plasmid DNA encoding influenza virus haemagglutinin induces Th1 cells and protection against respiratory infection despite its limited ability to generate antibody responses. J. Gen. Virol. 2000, 81:1737-1745.
12. Kashima Y., Ikeda M., Itoh Y., Sakoda Y., Nagata T., Miyake T., Soda K., Ozaki H., Nakayama M., Shibuya H., Okamatsu M., Ishigaki H., Ishida H., Sawai T., Kawaoka Y., Kida H., Ogasawara K. Intranasal administration of a live non-pathogenic avian H5N1 influenza virus from a virus library confers protective immunity against H5N1 highly pathogenic avian influenza virus infection in mice. Comparison of formulations and administration routes of vaccines. Vaccine 2009, 27:7402-7408.
13. Khanna M., Akther N., Srivastava V., Kumar P., Vijayan V.K. Biological and epidemiological aspects of influenza virus H5N1 in context of India. Idn. J. Exp. Biol. 2006, 44:265-278.
14. Kim J.H., Jacob J. DNA vaccines against influenza viruses. Curr. Top. Microbiol. Immunol. 2009, 333:197-210.
15. Kumar P., Sood V., Vyas R., Gupta N., Banerjea A.C., Khanna M. Potent inhibition of influenza virus replication with novel siRNA-chimeric-ribozyme constructs. Antiviral Res. 2010, 87:204-212.
16. Layne S.P., Monto A.S., Taubenberger J.K. Pandemic influenza: an inconvenient mutation. Science 2009, 323:1560-1561.
17. Lukacher A.E., Braciale V.L., Braciale T.J. In vivo effector function of influenza virus specific cytotoxic T lymphocyte clones is highly specific. J. Exp. Med. 1984, 160:814-826.
18. Luo M., Tao P., Li J., Zhou S., Guo D., Pan Z. Immunization with plasmid DNA encoding influenza A virus nucleoprotein fused to a tissue plasminogen activator signal sequence elicits strong immune responses and protection against H5N1 challenge in mice. J. Virol. Methods 2008, 154:121-127.
19. Machado A.V., Caetano B.C., Barbosa R.P., Salgado A.P.C., Rabelo R.H., Garcia C.C., Bruna-Romero O., Escrioue N., Gazzinellia R.T. Prime and boost immunization with influenza and adenovirus encoding the Toxoplasma gondii surface antigen 2 (SAG2) induces strong protective immunity. Vaccine 2010, 28:3247-3256.
20. Mackaness G.B., Blanden R.V. Cellular immunity. Prog. Allergy 1967, 11:89-140.
21. McFarland H.F. In vitro studies of cell-mediated immunity in an acute viral infection. J. Immunol. 1974, 113:173-180.
22. Okuda K., Ihata A., Watabe S., Okada E., Yamakawa T., Hamajima K., Yang J., Ishii N., Nakazawa M., Okuda K., Ohnari K., Nakajima K., Xin K.Q. Protective immunity against influenza A virus induced by immunization with DNA plasmid containing influenza M gene. Vaccine 2001, 19:3681-3691.
23. Ramsay A.J., Leong K.H., Ramshaw I.A. DNA vaccination against virus infection and enhancement of antiviral immunity following consecutive immunization with DNA and viral vectors. Immunol. Cell Biol. 1997, 75:382-388.
24. Reiss C.S., Schulman J.L. Influenza type A virus M protein expression on infected cells is responsible for cross-reactive recognition by cytotoxic thymus-derived lymphocytes. Infect. Immun. 1980, 29:719-723.
25. Robinson H.L., Pertmer T.M. DNA vaccines for viral infections: basic studies and applications. Adv. Virus Res. 2000, 55:1-74.
26. Tamizifar H., Jennings R., Ali S.A., Potter C.W. Induction of IL-2 and IFN-gamma in BALB/c mice immunised with subunit influenza A vaccine in combination with whole cell or acellular DTP vaccine. J. Med. Microbiol. 1997, 46:61-66.
27. Tao P., Luo M., Pan R., Ling D., Zhou S., Tien P., Pan Z. Enhanced protective immunity against H5N1 influenza virus challenge by vaccination with DNA expressing a chimeric hemagglutinin in combination with an MHC class I-restricted epitope of nucleoprotein in mice. Antiviral Res. 2009, 81:253-260.
28. Thomas P.G., Keating R., Hulse-Post D.J., Doherty P.C. Cell-mediated protection in influenza infection. Emerg. Infect. Dis. 2006, 12:48-54.
29. Ulmer J.B., Deck R.R., DeWitt C.M., Friedman A., Donnelly J.J., Liu M.A. Protective immunity by intramuscular injection of low doses of influenza virus DNA vaccines. Vaccine 1994, 12:1541-1544.
30. Vogel F.R. Improving vaccine performance with adjuvants. Clin. Infect. Dis. 2000, 30(Suppl. 3):S266-S270.
31. Webster R.G., Hinshaw V.S. Matrix protein from influenza A virus and its role in cross-protection in mice. Infect. Immun. 1977, 17:561-566.
32. Werner G.H. Humoral and cellular immunity in influenza virus infection. Bull. Acad. Natl. Med. 1993, 177:1263-1272.
33. Xu K., Ling Z.Y., Sun L., Xu Y., Bian C., He Y., Lu W., Chen Z., Sun B. Broad humoral and cellular immunity elicited by a bivalent DNA vaccine encoding HA and NP genes from an H5N1 virus. Viral Immunol. 2011, 24:45-56.
34. Yaya W., Donghua Z., Jinmei H., Wenli L., Hongsheng Z., Lu Z., Dan L., Zhenqian H., Huo T. Construction of HA-1-DC nucleic-acid vaccine and induction of specific cytotoxic T lymphocytes. J. Huazhong Univ. Sci. 2007, 27:261-264.
35. Zhang W., Li W., Li Y., Li H., Wang B., Wang F., Zhu Y., Jiang Z., Zhong L., Li M. Immune effects against influenza A virus and a novel DNA vaccine with co-expression of haemagglutinin- and neuraminidase-encoding genes. J. Med. Microbiol. 2009, 58:845-854.
36. Zhu X., Li T., Dang Y., Feng Y., Huang P. A novel in vitro transcription method for producing siRNAs without specific sequence requirements. Mol. Biotech. 2005, 31:187-194.